Mohamed Al-Rubeai
Overview
Explore the profile of Mohamed Al-Rubeai including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
78
Citations
3607
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tan F, Rui X, Xiang X, Yu Z, Al-Rubeai M
FASEB J
. 2021 Mar;
35(5):e21442.
PMID: 33774850
Cold atmospheric plasma (CAP) is an emerging technology for biomedical applications, exemplified by its antimicrobial and antineoplastic potentials. On the contrary, acidic fibroblast growth factor (aFGF) has been a long-standing...
2.
Tan F, Fang Y, Zhu L, Al-Rubeai M
Crit Rev Biotechnol
. 2021 Feb;
41(3):425-440.
PMID: 33622112
Cold atmospheric plasma (CAP) has been intensively researched for direct treatment of living cells and tissues. Significant attention is now being given to its indirect applications in plasma medicine. Surgical...
3.
Tan F, Fang Y, Zhu L, Al-Rubeai M
Stem Cell Res Ther
. 2020 Aug;
11(1):368.
PMID: 32847625
The stem cell is the foundation of regenerative medicine and tissue engineering. Regulating specific stem cell fate, such as cell attachment, proliferation, differentiation, and even death, undergoes continuous development. Cold...
4.
Tan F, Zhu Y, Ma Z, Al-Rubeai M
Acta Biomater
. 2020 Apr;
108:46-55.
PMID: 32289495
The surgical implant is an interdisciplinary therapeutic modality that offers unique advantages in the daily practice of otorhinolaryngology. Some well-known examples include cochlear implants, bone-anchored hearing aids, sinus stents, and...
5.
Tan F, Al-Rubeai M
Drug Deliv Transl Res
. 2020 Jan;
11(1):86-102.
PMID: 31898081
Implant-based local drug delivery is a unique surgical therapy with many clinical advantages. Atmospheric pressure plasma is a novel non-thermal surface biotechnology that has only recently been applied in enhancing...
6.
Tan F, Al-Rubeai M
Front Bioeng Biotechnol
. 2019 Oct;
7:247.
PMID: 31637236
Progression in implant science has benefited from ample amount of technological contributions from various disciplines, including surface biotechnology. In this work, we successfully used atmospheric plasma to enhance the biological...
7.
Zou W, Browne S, Al-Rubeai M
J Biotechnol
. 2019 Feb;
294:49-57.
PMID: 30768998
Growth-arrested strategies (e.g. hypothermia and hyperosmolarity) have been widely employed to enhance cell-specific productivity (qP) in mammalian cell culture bioprocess. In addition to enhanced qP, alterations in cell physiology, such...
8.
Zou W, Edros R, Al-Rubeai M
Biotechnol Appl Biochem
. 2017 Jul;
65(2):173-180.
PMID: 28681393
The growing demand for recombinant therapeutics has driven biotechnologists to develop new production strategies. One such strategy for increasing the expression of heterologous proteins has focused on enhancing cell-specific productivity...
9.
Alkhatib R, Hilal-Alnaqbi A, Naciri M, Al-Majmaie R, Saseedharan P, Karam S, et al.
Front Biosci (Schol Ed)
. 2016 Nov;
9(1):172-179.
PMID: 27814583
The lining epithelium of the stomach includes multipotent stem cells which undergo proliferation and migration-associated differentiation. These cells give rise to multiple cell lineages that produce mucus, acid, pepsinogen and...
10.
Klionsky D, Abdelmohsen K, Abe A, Abedin M, Abeliovich H, Arozena A, et al.
Autophagy
. 2016 Jan;
12(1):1-222.
PMID: 26799652
No abstract available.